[1] 薛耀明,邹梦晨.中国糖尿病足防治指南(2019版)解读[J].中华糖尿病杂志,2019,11(2):88-91. [2] 彭芳,张洋.糖尿病足患者感染多重耐药菌的病原学分布特点与危险因素临床效果评价[J]. 中国保健营养,2020,30(5):96-97. [3] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67. [4] 王前,王建中.临床检验学[M].北京:人民卫生出版社,2015:330-417. [5] 李世军,司全金.2017年欧洲心脏病学会外周动脉疾病诊断与治疗指南解读[J].中华老年心脑血管病杂志,2018,20(6):115-118. [6] 中国微循环学会糖尿病与微循环专业委员会.基层糖尿病微血管病变筛查与防治专家共识[J].中国医学前沿杂志(电子版),2018,10(2):17-25. [7] 中国医疗保健国际交流促进会糖尿病足病分会.中国糖尿病足诊治指南[J].中华医学杂志,2017,97(4):251-258. [8] 熊恩平,赖利,罗鲜花,等.糖尿病足医院感染的危险因素及负压引流对感染的控制效果探究[J]. 中华医院感染学杂志,2019,29(10):1509-1512. [9] Zubair M.Prevalence and interrelationships of foot ulcer, risk-factors and antibiotic resistance in foot ulcers in diabetic populations: A systematic review and meta-analysis[J]. World J Diabetes,2020,11(3):78-89. [10] Hicks CW,Canner JK,Mathioudakis N,et al.Incidence and risk factors associated with ulcer recurrence among patients with diabetic foot ulcers treated in a multidisciplinary setting[J]. J Surg Res,2020,246(5):243-250. [11] 徐薇,孙李永眷.糖尿病足患者发生MDR感染的病原菌、耐药性及其危险因素研究[J]. 湖南师范大学学报(医学版),2019,16(5):153-157. [12] Kurup R,Ansari AA.A study to identify bacteriological profile and other risk factors among diabetic and non-diabetic foot ulcer patients in a Guyanese hospital setting[J]. Diabetes Metab Syndr,2019,13(3):1871-1876. [13] Vibha SP,Kulkarni MM,Kirthinath Ballala AB,et al.Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus[J]. BMC Endocr Disord,2018,18(1):43. [14] 李刚,籍胤玺,冯延冰等.β-arrestin2、RBP4及FGF-21在2型糖尿病足中的表达及与糖脂代谢的关系研究[J].分子诊断与治疗杂志,2020,12(10):1328-1331. [15] Bekele F,Chelkeba L,Fekadu G,et al.Risk factors and outcomes of diabetic foot ulcer among diabetes mellitus patients admitted to Nekemte referral hospital, western Ethiopia: Prospective observational study[J]. Ann Med Surg (Lond),2020,18(5):17-23. [16] 陈燕,张蓓华.上海市≥60岁2型糖尿病患者下肢溃疡现状及影响因素[J].华南预防医学,2020,46(3):294-296. [17] 顾淑君,张秋伊,周正元,等.糖化血红蛋白变异指数与2型糖尿病患者糖尿病慢性并发症的相关性研究[J].华南预防医学,2021,47(4):431-435. |